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and the control of blood pressure. Ion transport along the DCT is tightly controlled by posttranscriptional
mechanisms including a complex interplay of kinases, phosphatases, and ubiquitin ligases. Previous work
identified the transcription factor Prox-1 as a gene significantly enriched in the DCT of adult mice. To
test if Prox-1 contributes to the transcriptional regulation of DCT function and structure, we developed a
novel mouse model (NCCcre:Prox-1flox/flox) for an inducible deletion of Prox-1 specifically in the DCT.
The deletion of Prox-1 had no obvious impact on DCT structure and growth independent whether the
deletion was achieved in newborn or adult mice. Furthermore, DCT-specific Prox-1 deficiency did not
alter DCT-proliferation in response to loop diuretic treatment. Likewise, the DCT-specific deletion of
Prox-1 did not cause other gross phenotypic abnormalities. Body weight, urinary volume, Na+ and K+
excretion as well as plasma Na+, K+, and aldosterone levels were similar in Prox-1DCTKO and Prox-
1DCTCtrl mice. However, Prox-1DCTKO mice exhibited a significant hypomagnesemia with a profound
downregulation of the DCT-specific apical Mg2+ channel TRPM6 and the NaCl cotransporter (NCC) at
both mRNA and protein levels. The expression of other proteins involved in distal tubule Mg2+ and Na+
handling was not affected. Thus, Prox-1 is a DCT-enriched transcription factor that does not control
DCT growth but contributes to the molecular control of DCT-dependent Mg2+ homeostasis in the adult
kidney.
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Abstract
The renal distal convoluted tubule (DCT) is critical for the fine-tuning of urinary ion excretion and the control of blood pressure.
Ion transport along the DCT is tightly controlled by posttranscriptional mechanisms including a complex interplay of kinases,
phosphatases, and ubiquitin ligases. Previous work identified the transcription factor Prox-1 as a gene significantly enriched in
the DCT of adult mice. To test if Prox-1 contributes to the transcriptional regulation of DCT function and structure, we developed
a novel mouse model (NCCcre:Prox-1flox/flox) for an inducible deletion of Prox-1 specifically in the DCT. The deletion of Prox-1
had no obvious impact on DCT structure and growth independent whether the deletion was achieved in newborn or adult mice.
Furthermore, DCT-specific Prox-1 deficiency did not alter DCT-proliferation in response to loop diuretic treatment. Likewise,
the DCT-specific deletion of Prox-1 did not cause other gross phenotypic abnormalities. Body weight, urinary volume, Na+ and




KO mice exhibited a significant hypomagnesemia with a profound downregulation of the DCT-specific apical Mg2+
channel TRPM6 and the NaCl cotransporter (NCC) at both mRNA and protein levels. The expression of other proteins involved
in distal tubuleMg2+ and Na+ handlingwas not affected. Thus, Prox-1 is a DCT-enriched transcription factor that does not control
DCT growth but contributes to the molecular control of DCT-dependent Mg2+ homeostasis in the adult kidney.
Keywords Kidney . Renal distal convoluted tubule (DCT) . DCT adaptation . Transcription factor Prox-1 . NaCl cotransporter
(NCC) . Transient receptor potential cation channel subfamilyMmember 6 (TRPM6)
Introduction
The renal distal convoluted tubule (DCT) is crucial for the con-
trol of ion homeostasis and the regulation of arterial blood pres-
sure [28]. Although only 5–10% of the sodium (Na+) filtered at
the glomerulus is reabsorbed in the DCT, the Na+ transport
activity of the DCT is the highest of all nephron portions, which
is reflected by a very high mitochondrial density in DCT cells.
The Na+ transport in the DCT is driven by the basolateral Na+-
K+-ATPase and critically depends on the activity of the thiazide-
sensitive NaCl cotransporter (NCC) in the apical plasma mem-
brane of DCT cells [28, 30]. The DCT is also important for the
control of renal magnesium (Mg2+) excretion as the DCT is the
sole site for active transcellular Mg2+ reabsorption along the
nephron. The Mg2+ reabsorption in the DCT is mediated by
the apical transient receptor potential cation channel subfamily
M member 6 (TRPM6) [46] and modulated by the γ-subunit of
the Na+-K+-ATPase encoded by the FXYD2 gene [2, 27].
Genetic diseases affecting the DCT evidence the signifi-
cance of the DCT for the control of ion homeostasis and blood
pressure [28]. In Gitelman syndrome, loss-of-function muta-
tions in NCC lead to an autosomal recessive renal tubulopathy
characterized by renal salt-wasting with low blood pressure,
hypokalemic alkalosis, hypocalciuria, and hypomagnesemia
[40]. Conversely, an inappropriate increase in NCC activity
due tomutations in NCC-regulating with no lysine (K) kinases
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(WNK1 and 4) or ubiquitin ligase complexes (KLHL3,
CUL3) causes salt-sensitive familial hyperkalemic hyperten-
sion (FHHt) with metabolic acidosis and hypercalciuria, also
known as Gordon syndrome or pseudohypoaldosteronism
type II (PHA II) [12, 28, 41]. Likewise, mutations in
TRPM6 [36, 48] and FXYD2 [29] cause renal tubulopathies
with magnesium wasting and hypomagnesemia [45].
The last couple of years brought tremendous insights into the
molecular signaling mechanism that control the function of the
DCT. A complex network of various kinases, phosphatases,
and ubiquitin ligases was shown to regulate the DCT function.
For example, the STE20-related proline-alanine–rich kinase
(SPAK) and the oxidative-stress-responsive 1 kinase (OSR1)
are known to directly phosphorylate and thereby activate NCC
[13]. The activity of SPAK and OSR1 itself is controlled by the
upstream kinases WNK1 and WNK4 [51] that again are regu-
lated via the ubiquitin ligase complex proteins kelch-like 3
(KLHL3) and cullin 3 (CUL3) [13, 41]. The abundance of
NCC is also directly regulated by ubiquitinylation via Nedd4–
2 and the upstream kinase Sgk1 [34]. Phosphatases such as
protein phosphatase 1 (PP1), 3 (PP3 or calcineurin), and 4
(PP4) can counteract the activity of the kinases and inactivate
NCC [11]. Similar to NCC, the activity of TRPM6 is also
controlled by several kinases. For example, the stimulatory ef-
fect of the epidermal growth factor (EGF) on TRPM6 is
thought to be mediated by both Src-Family Kinases and
mitogen-activated kinases (MAPK) and their downstream me-
diator PI3-kinase [43]. Likewise, AKT/PKB and Cdk5 were
implicated in the insulin-dependent regulation of TRPM6 [45].
Despite this significant progress, we still lack a comprehen-
sive understanding of the regulatory mechanisms that govern
the DCT. In particular, we lack significant information about
the transcriptional control mechanism. Genetic studies linked
the hepatocyte nuclear factor 1 beta (HNF1b) and its cofactor
PCBD1 to the regulation of TRPM6 [1, 20], but the role of
other DCT-expressed transcription factors is less clear.
Previously, we identified the transcription factor Prospero
Homeobox 1 (Prox-1) as a gene that is about 100 times more
abundant in the DCT than in in the sum of all other renal
tubules of adult mouse kidney [33]. Together with NCC and
TRPM6, Prox-1 belongs to the 20 gene products most
enriched in the mouse DCT suggesting a specific role in this
tubule segment. Also in the adult rat kidney, Prox-1 appears to
be predominately if not exclusively expressed in the DCT as
indicated by a comprehensive database on RNAseq data from
isolated renal tubules [23].
Prox-1 is a transcription factor containing an evolutionary
conserved homeobox-prospero domain that binds DNA and
RNA and allows transcriptional regulation of other genes. It
plays an essential role during developmental processes such as
cell proliferation, cell fate determination, and progenitor cell dif-
ferentiation in numerous mammalian organs (lymphatic system,
CNS, eye, heart, liver, and pancreas) [8, 10, 32, 49]. Moreover,
alterations in Prox-1 expression have been associated with sev-
eral humanmalignancies including hematological diseases; brain
tumors; and carcinomas of colon, pancreas, and liver, and the
biliary system [10, 32]. In the kidney, Prox-1 is highly expressed
in distal tubules of the developing mouse kidney where it
is involved in differentiation and outgrowth of themedullary part
of the loop of Henle [17]. As in the adult kidney, Prox-1 is
enriched in the DCT [23, 33], we hypothesized that Prox-1
may contribute to the transcriptional control of DCT function.
As a constitutive Prox-1 knockout is embryonically lethal [50],
we developed a novel mouse model that allowed an inducible,
DCT-specific deletion of Prox-1 in the adult kidney.
Material and methods
Animals
Mice with “floxed” alleles for Prox-1 were a kind gift from Dr.
G. Oliver (Chicago, USA). In this conditional knockout mouse
model, exons 2 and 3 of the Prox-1 gene are flanked by loxP
sites. Cre recombinase mediated deletion of these two exons
removes the homeodomain and Prox domain and renders Prox-
1 transcriptionally inactive [14]. To target specifically the DCT,
a mouse model with a tamoxifen-inducible cre activity in the
DCT was custom-made by the company Ozgene (Bentley,
Australia). In these mice, the cre-ERT2 was introduced into
the three prime untranslated region (3′-UTR) of the Slc12a3/
NCC gene, where it is expressed using the same internal ribo-
somal entry site (IRES) as the Slc12a3/NCC gene (Fig. 1A).
TdTomato-red reporter mice [26] were obtained from The
Jackson Laboratories Repository. All experiments involving
living animals were conducted in accordance with Swiss laws
and approved by the veterinary administration of the Canton of
Zurich (Kantonales Veterinäramt), Switzerland.
Tamoxifen administration
Tamoxifen induction was performed in male mice 1–2 weeks
after weaning (i.e., at the age of 35–45 days). Tamoxifen
(Sigma-Aldrich, T5648) was dissolved in EtOH: sunflower
oil (1:10). A dose of 2 mg per day was administered to the
mice via gastric gavage on 5 subsequent days, 6 weeks prior to
the experiments. The same dosage and procedure were ap-
plied to breastfeeding mother mice to induce cre expression
in the newborn offspring.
Plasma and urine ion measurement
Blood collection Blood was sampled by puncture of the infe-
rior vena cava of isoflurane-anesthetized animals. Whole
blood was centrifuged for 10 min at 3000 g and plasma was
removed subsequently.
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Plasma Na+, K+, and Ca2+measurement Blood ions (Na+, K+,
Ca2+) were measured with the ABL80Flex Blood Gas
Analyzer (Radiometer, Copenhagen, Denmark).
Plasma and urine Mg2+ and PO4
3− measurement Plasma and
urine Mg2+ and PO4
3− measurements were performed by the
Zurich Integrative Rodent Physiology (University of Zurich)
using photometric methods (UniCel DxC 800, Beckman
Coulter, Brea, CA, USA).
Urine Na+, K+, and Ca2+measurementUrine was collected for
24 h from mice kept individually in metabolic cages
(Tecniplast S.p.A., Buguggiate, Italy). Urinary electrolytes
(Na+, K+, Ca2+) were measured by flame photometry
Fig. 1 Characterization of NCC-
cre-ERT2 mice. A Schematic
representation of insertion of the
tamoxifen-inducible creERT2 in
the untranslated region (UTR) of
the last exon of the Slc12a3/NCC
gene. B Immunostaining for
NCC, cre, and calbindin D28K
(CB28) on consecutive cryosec-
tions from NCC-cre-ERT2 mice.
Tamoxifen induces strong nuclear
localization of the cre
recombinase in NCC-positive
DCT1 (1) and in DCT2 (2) with
strong NCC and CB28-immuno-
staining.COverviews on kidneys
from NCC-cre-ERT2/tomato-flox
mice (upper panel) show a strong
tomato-related fluorescence in a
kidney of tamoxifen-induced but
not in the kidney of an uninduced
mouse. High-power magnifica-
tion (lower panel) demonstrate
that the tomato-related fluores-
cence is strictly limited to the
DCT (D) and is not found in the
preceding NKCC2-positive TAL
(T) and the downstream localized
AQP2-positive CNT (CN). The
segment transitions are indicated
by double-headed arrows. Two
pairs of consecutive cryosections.
D and E Immunoblots and densi-
tometry reveal that the creERT2
transgene does not interfere with
NCC abundance and phosphory-
lation. Data are mean ± SEM, n =
3
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(EFOX 5053, Eppendorf, Hamburg, Germany). Urine creati-
nine was assessed by the Jaffe method.
Aldosterone, 11-deoxycorticosterone, and
corticosterone measurement
Aldosterone, 11-deoxycorticosterone, and corticosteronewere
determined by ultra-performance liquid chromatography-MS/
MS (UPLC-MS/MS) as described previously with minor ad-
aptations [42] using an Agilent 1290 Infinity II UPLC coupled
to an Agilent 6495 triple quadrupole mass spectrometer. Data
acquisition and quantitative analysis was performed by
MassHunter (Version B.10.0. Build 10.0.27, Agilent
Technologies).
Kidney harvesting and tissue processing
Immunofluorescence The kidneys of isoflurane-anesthetized
adult mice were fixed by retrograde abdominal aortic perfu-
sion of 3% paraformaldehyde (PFA) followed by rinsing with
0.1 M phosphate buffer (pH 7.4, 300 mOsm) and paraffin
embedding. The kidneys of 10-day-old isoflurane-
anesthetized pups were immersion fixed with paraformalde-
hyde (PFA) 3% for 12–16 h, then incubated in 0.1 M phos-
phate buffer (pH 7.4, 300 mOsm) for 4 h and finally embed-
ded in paraffin.
Western blot and quantitative reverse transcription PCR For
western blot analysis and RNA extraction, perfusion was per-
formed with PBS (pH 7.4) via the left ventricle of the heart;
kidneys were removed and frozen in liquid nitrogen.
Immunohistochemistry
Tissue blocks were sectioned at 4 μm on a standard rotary
microtome (Microm HM355S, Thermo Fisher Scientific,
Waltham, MA, USA). The Pathisto AS-2 automatic slide
stainer (Pathisto GmbH, Garbsen, Germany) was utilized for
deparaffination using Histo-clear and for tissue rehydration
using serial ethanol washes. For epitope retrieval, slides were
heated in 10 mM citrate buffer (pH 6.0) in a microwave
(98 °C, 10 min). After blocking with 10% normal goat serum
(10 min), the sections were incubated overnight in a humidi-
fied chamber at 4 °C with the primary antibodies. The dilu-
tions of the previously generated und described primary anti-
bodies are shown in supplementary table 1. Secondary anti-
bodies (Cy3-conjugated goat-anti-rabbit IgG, catalogue code
111–165-144, dilution 1/1000 and FITC-conjugated goat-
anti-mouse IgG, catalogue code 115–095-068, dilution
1/100, both from Jackson Immuno Research Laboratories,
West Grove, PA) were applied for 2 h at room temperature
and sections were finally mounted using DABKO-glycergel
and coverslips. Images were acquired at a Leica DM6000 B
fluorescence microscope on Leica DFC350 FX fluorescence
monochrome digital camera (Leica Microsystems, 35578
Wetzlar, Germany).
Western blot analysis
Sample preparation Kidneys were homogenized in ice-cold
lysis buffer (Mannitol 200 mM, HEPES 80 mM, KOH
41 mM) containing protease inhibitor (Complete Ultra,
Roche) and phosphatase inhibitor (PhosSTOP, Roche) using
MagNA Lyser Green Beads (Roche) and Precellys 24 tissue
homogenizer (Bertin Instruments), 2 × 20 s (2000 g). The ho-
mogenized samples were centrifuged for 10 min (1700 g) and
the protein-containing supernatant was removed and stored at
− 80 °C.
SDS-PAGE andWestern blot Equal amounts of protein (25 μg)
from kidney samples were denatured in Laemmli Buffer
(SDS, β-mercaptoethanol, bromophenol blue, glycerol and
0.5 M Tris-HCl buffer, pH 6.8), separated by SDS-page, and
electrophoretically transferred onto nitrocellulose membranes.
The membranes were blocked with Odyssey Blocking solu-
tion (LI-COR Biosciences) (10 min) and then incubated at
4 °C for 16 h with the primary antibodies (see table 1 of
supplementary data) diluted in Odyssey Blocking buffer:
PBS (1:5). After repeated washes with PBS, blots were incu-
bated at room temperature for 2 h with secondary antibodies
(goat-anti-rabbit IRDye 800, product number 926-32211 and
goat-anti-mouse IRDye 680, product number 926-32220,
1:20′000, both from LI-COR Biosciences), in Casein
Blocking solution: H2O (1:10). Immunoreactive bands were
visualized and quantifiedwith the Odyssey IR imaging system
and software (LI-COR Biosciences) and normalized for either
β-actin or the total protein signal obtained by REVERT Total
Protein Stain (LI-COR Biosciences).
RNA isolation and quantitative PCR
RNA isolation and cDNA generation from total kidney tissue
Total RNA from kidney tissue was isolated using Promega kit
(SV Total RNA Isolation System, catalog number Z3100),
according to the manufacturer’s protocol. cDNA was gener-
ated using Promega kit (GoScript™ Reverse Transcription
System, catalog number A5000) as per the manufacturer pro-
tocol. For whole kidney tissue, cDNA was further diluted to
1:5 in H2O.
RNA isolation and cDNA generation from isolated DCTs
Manually microdissected tubules were frozen in RNA lysis
buffer containing β-mercaptoethanol, and RNA was isolated
using Absolutely RNA Nanoprep kit (Agilent Technologies,
catalog number 400753), following manufacturer’s protocol.
cDNA was generated using Sensifast cDNA Synthesis kit
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(Bioline, catalog number BIO65053), and undiluted cDNA
was used for RT-qPCR.
Real-time quantitative PCR Expression levels of the genes of
interest were quantified by real-time quantitative PCR using
Light Cycler II 480 (Roche). Real-time PCR reactions were
prepared using 5.0 μl of LightCycler 480 SYBR Green I
Master (Roche), 3.75 μl of RNase free water, 0.25 μl of each
primer (100μM), and 0.75μl of cDNA (final reaction volume
of 10 μl). Gene-specific primer sequences are listed in table 2
of supplementary data. Specificity of the primers was first
tested in a standard PCR with subsequent separation of PCR
products in a 2% agarose gel. Relative mRNA gene expres-
sion was measured after normalization to GAPDH gene ex-
pression (total kidney) and ribosomal RNA gene expression
(isolated DCTs).
Manual microdissection of distal convoluted tubules
Manual microdissection of distal convoluted tubules was con-
ducted according to a previously published protocol [47].
After perfusion of anesthetized mice with MEM media
(GibcoBRL, Ref number 11058021) via left ventricle, the
kidney was sagittally cut into two halves and the medulla
was excised. Cortex was sliced into 1-mm thin sections that
were then incubated in a digestion solution containing 4 ml
MEM, 5 mM glycine, 6 mg/ml trypsin inhibitor (Trypsin in-
hibitor from Glycine max, Sigma-Aldrich, T9128), and
250 μg/ml collagenase (Collagenase from Clostridium
histolyticum, Sigma-Aldrich, C9891), pH 7.4 at 37 °C for
25 min without shaking. The digested cortex sections were
subsequently washed with ice-cold HEPES solution (NaCl
125 mM, KCl 3 mM, MgSO4 1.2 mM, CaCl2 1 mM,
KH2PO4 2 mM, glucose 5 mM, HEPES 32.2 mM), and the
renal DCTs were manually microdissected under a stereomi-
croscope based on their distinct morphological characteristic.
Implantation of mini-osmotic pump
Loading mini-osmotic pumps Bumetanide (Sigma-Aldrich,
B3023) (dosage of 40 mg/kg body weight/day) and
bromodeoxyuridine (Sigma-Aldrich, B5002) (dosage
40 mg/kg body weight/day) were dissolved in H2O:
PEG300 (1:5) with incubation on a thermo shaker on 36 °C,
1000 rpm, overnight. Mini-osmotic pumps from Alzet®
(model 2001, DURECT Corporation, Cupertino, CA, USA)
with a filling volume of 200 μl and a pump delivery rate of
1 μl/h were used. One day prior to pump implantation, the
mini-osmotic pumps were loaded with appropriate volume
(200 μl) of the solution as directed by manufacturer using
the provided needle. The loaded mini-osmotic pumps were
primed in sterile NaCl 0.9% at 37 °C overnight according to
the supplier’s instruction.
Surgical implantation in mice Mice were anesthetized with
isoflurane and buprenorphine 0.01 mg/kg body weight
(Temgesic®, 0.3 mg/ml, Indivior Schweiz AG, 3015880).
For implantation of the pump, mice were placed in a prone
position. A skin incision (1–2 cm) was made across the neck
and a subcutaneous pocket was created using blunt forceps.
After inserting the pump into the subcutaneous pouch, the skin
wound was closed with two surgical clips.
Semi-thin sections
For semi-thin sectioning, kidneys were fixed by vascular per-
fusion with 3% PFA as described above and postfixed in the
same fixative to which 1% glutaraldehyde was added. The
tissue was embedded in epoxy resin (EPON) and semi-thin
sections of 0.8 μm were cut with an ultramicrotome (Leica
UltraCut E ultramicrotome). For staining, slides were incubat-
ed at 60 °C for 2 min in 0.5% toluidine blue (Merck, 11593)
and 0.5% sodium tetraborate decahydrate (Sigma-Aldrich,
S9640), diluted in water, followed by coverslip mounting with
Entellan new (Merck 1079610100).
Morphometric measurements
The fractional cortical tubular volume of DCT segments was
assessed according to a previously described protocol [38].
Paraffin sections of kidneys were immunostained with an an-
tibody against NCC (table 1 of supplementary material) and
images were taken from each kidney section with the × 10
objective of the fluorescence microscope. DCTs were
Fig. 2 Prox-1, Slc12A1/NKCC2, Slc12A3/NCC, and AQP2 mRNA
expression in Prox-1DCT
Ctrl versus Prox-1DCT
KO isolated DCTs and in
total kidney tissue. Prox-1: Prox-1 gene expression is significantly in-
creased in isolated DCTs (Prox-1DCT
Ctrl) compared to whole kidney tis-
sue (Prox-1DCT
Ctrl) (p = 0.0035). Confirmation of a Prox-1 deletion with
almost none Prox-1 mRNA expression in isolated DCTs from Prox-
1DCT
KO mice compared to isolated DCTs from Prox-1DCT
Ctrl mice (p =
0.000006). Slc12A1/NKCC2, AQP2: No contamination of isolated
DCTs (Prox-1DCT
Ctrl and Prox-1DCT
KO) with other nephron segments,
confirmed by absent Slc12A1/NKCC2 and AQP2 gene expression in
DCT samples. Slc12A3/NCC: 20–30-fold higher Slc12A3/NCC expres-
sion in isolated DCTs compared to total kidney tissue. Kidneys and renal
tubules were isolated 1 week after start of tamoxifen induction. Data are
mean ± SEM, expressed as fold difference compared to the gene expres-
sion in the total kidney group, n = 5
Pflugers Arch - Eur J Physiol
identified according to the antibody-staining pattern and the
fractional cortical tubular volumes for DCTs were determined
using a planimetric point-counting method performed with a
computerized image analysis system (Stereo Investigator,
MBF Bioscience, Williston USA).
Statistical analysis
Unpaired two-tailed t test and 2-way ANOVA were used to
compare the groups (GraphPad Prism, Version 8.0.2). Data
are given as means ± SEM. Values were considered as signif-
icantly different when p < 0.05.
Results
Development and characterization of a new mouse
model for inducible DCT-specific gene targeting
For a DCT-specific deletion of Prox-1, we first devel-
oped and characterized a novel mouse model with a
tamoxifen-inducible cre activity in the DCT (see
“Material and methods”). Upon tamoxifen administra-
tion, these mice show a strong nuclear localization of
the cre recombinase specifically in the DCT (Fig. 1B),
comprising both DCT1 and DCT2 as identified by their
characteristic staining pattern for NCC and calbindin
D28K [24]. Using a tdTomato-red reporter mouse line
[26], we found that cre-mediated recombination is neg-
ligible without tamoxifen induction, but increases dras-
tically in cortical tubules when tamoxifen is adminis-
tered for 5 days. Higher magnifications showed that
the cre-mediated recombination starts precisely at the
transition from TAL to DCT and ends at the transition
from DCT to CNT (Fig. 1C). Immunoblotting confirmed
that the insertion of the cre-ERT2 in the 3′UTR of NCC
does not interfere with NCC expression and phosphory-
lation (Fig. 1D, E). Thus, this new NCC-cre-ERT2
mouse model allows a timed gene targeting restricted
to the DCT. Unlike to a recently published mouse mod-
el with constitutive cre expression under the control of
the NCC promoter [44], the new mouse model does not
show evidence for cre-mediated recombination in non-
DCT cells. Similar observations were made by the
group of Jim McCormick who just reported a similar
NCC-c re -ERT2 mouse mode l gene ra t ed by a
similar gene-modification strategy as we employed [5].
Prox-1 is enriched in adult mouse DCT
Prox-1 mRNA expression was determined in manually
dissected DCTs from both Prox-1DCT
Ctrl and Prox-
1DCT
KO mice as well as from total kidney homogenates
from Prox-1DCT
Ctrl mice. Comparing Prox-1 mRNA
abundance in isolated DCT segments (ctrl) and total
kidney tissue (ctrl), Prox-1 mRNA transcript levels
showed a 5–6-fold enrichment in the DCT (Fig. 2). In
the Prox-1DCT
KO mice, hardly any Prox-1 expression
was detectable in the isolated DCTs, confirming the
efficacy of the DCT-specific Prox-1 deletion in our
mouse model (Fig. 2). Isolated DCTs were not contam-
inated with other tubular segments, confirmed by absent
Slc12A1/NKCC2 and AQP2 gene expression.
No gross pathological characteristics in Prox-1DCT
KO
mice
Breeding of NCC-cre-ERT2 with floxed Prox-1 animals
resulted in a normal Mendelian inheritance pattern. Cre-
induction and excision of the Prox-1 gene in DCT cells
were induced upon tamoxifen administration either im-
mediately after birth or at the age of weaning.
Independent from the time point of induction, all mice
with DCT-specific Prox-1 deletion (Prox-1DCT
KO) did
Table 1 Metabolic parameters, plasma and urine electrolyte






Age (days) 90 ± 1 100 ± 3
Body weight (g) 31.3 ± 0.9 31.6 ± 1.0
Food intake (g/day) 7.3 ± 0.6 5.9 ± 0.3
Water intake (ml/day) 2.6 ± 0.6 3.3 ± 0.8
Urine volume (ml/day) 1.2 ± 0.3 1.1 ± 0.3
Plasma Na+ (mmol/l) 149.4 ± 0.6 150.9 ± 1.3
Plasma K+ (mmol/l) 4.0 ± 0.1 4.1 ± 0.2
Plasma Ca2 + − (mmol/l) 1.26 ± 0.03 1.25 ± 0.03
Plasma Mg2+ (mmol/l) 0.85 ± 0.03* 0.76 ± 0.03*
Plasma HCO3− (mmol/l) 19.3 ± 0.5 20.0 ± 0.5
Plasma PO43−(mmol/l) 1.61 ± 0.12 1.83 ± 0.15
Plasma aldosterone (nM) 0.32 ± 0.04 0.37 ± 0.09
Plasma 11-Deoxycorticosterone (nM) 1.38 ± 0.36 0.98 ± 0.37
Plasma corticosterone (nM) 107.7 ± 20.8 92.9 ± 19.0
Urine Na+/urine creat. (mmol/mmol) 40.8 ± 6.0 41.4 ± 4.0
Urine K+/urine creat. (mmol/mmol) 179.4 ± 17.2 147.6 ± 11.3
Urine Ca2+/urine creat. (mmol/mmol) 0.84 ± 0.14 0.60 ± 0.12
Urine Mg2+/urine creat. (mmol/mmol) 3.70 ± 1.13 1.83 ± 0.77
Prox-1DCT
KO mice exhibit a significant hypomagnesemia (p = 0.036)
compared to the Prox-1DCT
Ctrl group. For other metabolic parameters,
plasma electrolytes, plasma aldosterone, 11-deoxycorticosterone, cortico-
sterone, and urinary ion excretion, no difference was detected between the
genotypes. Values are means ± SEM. n = 11 (plasma electrolytes), n = 13
(plasma Mg2+ ), n = 7 (aldosterone, 11-deoxycorticosterone, and cortico-
sterone), n = 5 (body weight, food and water intake, urine excretion, urine
electrolytes)
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Fig. 3 DCT morphology and fractional cortical volume of DCT in Prox-
1DCT
Ctrl versus Prox-1DCT
KO mice at age 10 days and 6 weeks. A NCC
protein expression (immunostaining on paraffin sections) in kidneys of
10-day-old pups (upper panel) and 6-week-old (lower panel) Prox-
1DCT
Ctrl versus Prox-1DCT
KO mice. Cre recombination and deletion of
Prox-1 in the DCT was induced immediately after birth. B No difference
in the fractional cortical volume (%) of whole DCT in Prox-1DCT
Ctrl
versus Prox-1DCT
KO mice was observed upon deletion of Prox-1, neither
in pups nor in 6-week-old mice. DCTs were identified due to NCC im-
munostaining. Values are means ± SEM. n = 4 (10 days, ctrl + ko), n = 6
(6 weeks, ctrl), n = 5 (6 weeks, ko).CDistal convoluted tubules (D) in the
renal cortex of Prox-1DCT
Ctrl and Prox-1DCT
KOmice reveal a normal DCT
morphology (adult kidneys) in both genotypes, epon semi-thin sections
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not show a gross pathological phenotype. Body weight,
food, and water intake and 24-h urine excretion were
comparable among the genotypes (Table 1).
No effect of a Prox-1 deletion on DCT development
and outgrowth
To address the question whether Prox-1 influences the out-
growth of the DCT during renal development, Prox-1 deletion
was induced in newborn mice via tamoxifen gavage of the
breastfeeding mother during the first 5 days after birth. So-
treated mice were sacrificed 10 days and 6 weeks after birth
and kidneys were collected for further analysis. Based on par-
affin sections of kidneys immunostained with antibody
against NCC, DCTs were identified and the fractional cortical
tubular volume for DCTs was determined using a planimetric
point-counting method (morphometry). Neither a change in
kidney morphology nor in the cortical tubular DCT volume
was observed in Prox-1DCT
KO mice compared to Prox-
1DCT
Ctrl mice both 10 days and 6 weeks after birth (Fig. 3A,
B). Morphologic analysis of the renal cortex (epon semi-thin
sections) in both control and Prox-1DCT
KO mice revealed no
structural abnormalities of the DCT epithelium in response to
a genetic loss of Prox-1 (Fig. 3C).




KO mice in response to a 3-
day treatment with bumetanide.A
Paraffin sections of Prox-1DCT
Ctrl
mice kidneys (upper panel) and
Prox-1DCT
KO mice kidneys (low-
er panel) after a 3-day treatment
with bumetanide and BrdU (right)
or BrdU only (left). A double-
immunostaining for NCC (red)
and BrdU (green) allowed for the
identification of DCT segments
and proliferating DCT cells. B A
significant increase in DCT cell
proliferation rate was achieved in
Prox-1DCT
Ctrl (p = 0.0001) and
Prox-1DCT
KO (p = 0.0007) by the
administration of bumetanide and
BrdU compared to the situation
where mice received BrdU only.
However, no difference in the
proliferation rate between the dif-
ferent genotypes was observed.
Data are mean ± SEM, n = 6
(BrdU only), n = 5 (Bumetanide +
BrdU, ctrl), n = 4 (Bumetanide +
BrdU, ko)
Pflugers Arch - Eur J Physiol
Deletion of Prox-1 does not influence DCT cell prolif-
eration rate in response to a 3-day treatment with
bumetanide
To test whether Prox-1 is involved in epithelial remod-
eling processes of the DCT that occur in response to a
loop diuretic treatment, bumetanide was applied contin-
uously during 3 days. The simultaneous administration
of bromodeoxyuridine (BrdU) allowed for the detection
of DCT cell proliferation rate. After the bumetanide
treatment, a significant increase in DCT cell prolifera-
tion rate was observed in the group that received bu-
metanide plus BrdU compared to the group that was
treated with BrdU only (Fig. 4A). However, quantitative
analysis of the percentage of proliferating DCT cells
under the bumetanide treatment revealed no difference
in the proliferation rate between Prox-1DCT
KO versus
Prox-1DCT
Ctrl mice (Fig. 4B).
Overt hypomagnesemia, but no other changes in
plasma electrolytes and urinary ion excretion in Prox-
1DCT
KO mice
Analysis of plasma electrolytes revealed a significant hypo-
magnesemia in Prox-1DCT
KO mice, whereas no differences in
other plasma electrolyte concentrations (Na+, K+, Ca2+, phos-
phate) and plasma aldosterone, 11-dehydrocorticosterone and
corticosterone levels between the knockout and control
groups were detected (Table 1). Urinary ion excretion
(Na+, K+, Ca2+, Mg2+) was similar in Prox-1DCT
Ctrl and
Prox-1DCT
KO mice (Table 1).
Fig. 5 NCC and phospho-NCC protein and mRNA abundance in Prox-
1DCT
Ctrl versus Prox-1DCT
KO mice. A Protein expression of total NCC
and pT58-NCC in total kidney homogenates of Prox-1DCT
Ctrl versus
Prox-1DCT
KO mice. B Densitometry analysis reveals a significant down-
regulation of total NCC (p = 0.0083) and in pT58-NCC (p = 0.0002) pro-
tein expression in Prox-1DCT
KO compared to the control group. Data are
mean ± SEM, n = 7 C Gene expression of NCC in total kidney homog-
enates of Prox-1DCT
Ctrl versus Prox-1DCT
KO mice reveals a significant
downregulation of mRNA (p = 0.049) in Prox-1DCT
KO compared to the
control group. Data are mean ± SEM, n = 7. Kidneys were studied
6 weeks after start of tamoxifen induction
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Decreased NCC abundance due to a loss of Prox-1 in
the DCT
Deletion of Prox-1 in the DCT in adult mice for 6 weeks
resulted in a significant downregulation of total NCC
and phospho-NCC protein abundance in total kidney
homogenates of Prox-1DCT
KO compared to Prox-
1DCT
Ctrl (Fig. 5A, B). Similar results were shown for
NCC gene expression (Fig. 5C). Interestingly, downreg-
ulation of NCC mRNA was less pronounced at 1 week
after tamoxifen induction (Fig. 2), suggesting that the
downregulation of NCC at the mRNA level is not an
immediate effect.
No change in ENaC protein expression in Prox-1DCT
KO
mice
Protein expression analysis for α-, β-, and ɣ-ENaC revealed
no significant difference in kidneys of Prox-1DCT
Ctrl and Prox-
1DCT
KO mice for both the total/glycosylated and the cleaved
forms of ENaC (Fig. 6A, B).
Reduced protein expression of the DCT-specific Mg2+
channel TRPM6 in Prox-1DCT
KO mice
A significant reduction in the protein expression of the DCT-
specific Mg2+ channel TRPM6 was observed in total kidney
Fig. 6 ENaC protein abundance in Prox-1DCT
Ctrl versus Prox-1DCT
KO




Densitometry analysis reveals no significant regulation of ENaC in
Prox-1DCT
KO compared to the control group. Data are mean ± SEM,
n = 7. Kidneys were studied 6 weeks after start of tamoxifen induction
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homogenates of Prox-1DCT
KO mice (Fig. 7A, B). In parallel,
TRPM6 mRNA expression was also significantly reduced
(Fig. 8A). mRNA levels of other renal magnesium trans-
porters and proteins involved in Mg2+ homeostasis (EGF,
CNNM2, EGF, FXYD2, Cldn16, Cldn19, TRPM7,
Slc41a1–3) in total kidney homogenates were not altered in
Prox-1DCT
KO mice compared to their control littermates
(Fig. 8B–L).
Discussion
Transcription factors are proteins that bind to particular DNA
sequences in gene regulatory regions and control gene expres-
sion and activity [22]. The human genome encodes about
1600 regulatory sequence-specific transcription factors that
have been identified and functionally characterized [15].
With the exception of the steroid receptors (e.g., the mineral-
ocorticoid receptor), most studies addressing the role of tran-
scription factors in the kidney focus on their significance dur-
ing embryonic development and their regulatory function in
nephrogenesis and differentiation of nephron progenitor cells
[3]. Accordingly, gene mutations in transcription factors have
been associated with congenital renal malformations and
inherited diseases, emphasizing their important role during
renal embryogenesis. For example, mutations in the
transcription factor hepatocyte nuclear factor 1 homeobox B
(HNF1B) gene have been shown to cause renal
malformations, hypomagnesemia, and maturity-onset diabe-
tes of the young (MODY) [1, 20]. Part of this phenotype
was suggested to be related to a transcriptional downregula-
tion of the basolateral Kir4.1/Kir5.1 K+ channel in the DCT
[19]. In contrary to the evolving knowledge of the role of
transcription factors during renal development, only little is
known about transcriptional control and regulation of gene
expression in the adult kidney. Interestingly, the DCT tran-
scriptome established previously [7, 23, 33] revealed a high
number of enriched DCT genes known to be involved in tran-
scriptional regulation and growth control during renal devel-
opment and/or tumorigenesis, suggesting that this “embryo-
logical” transcriptome contributes to the characteristic adapta-
tion capacity and plasticity exhibited by the DCT in the adult
stage.
Given its regulatory function in cell proliferation in other
organs such as the retina [8], muscle tissue [18], central ner-
vous system [16], and lymphatic tissue [49], we hypothesized
that Prox-1 might play a role in DCT epithelium structural
remodeling processes that occur in response to a loop diuretic
treatment. However, after a 3-day treatment with bumetanide,
no difference in the DCT cell proliferation rate was observed
in the Prox-1DCT
KO mice compared to the Prox-1DCT
Ctrl
group. A direct effect of Prox-1 on DCT cell proliferation
Fig. 7 TRPM6 protein and mRNA abundance in Prox-1DCT
Ctrl versus
Prox-1DCT




Densitometry analysis reveals a significant down-regulation of TRPM6
(p = 0.0317) protein expression in Prox-1DCT
KO compared to the control
group. Data are mean ± SEM, n = 5. Kidneys were studied six weeks after
start of tamoxifen induction
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Fig. 8 mRNA expression of Mg2+ channels and regulatory proteins
involved in Mg2+ homeostasis in Prox-1DCT
Ctrl versus Prox-1DCT
KO
mice (total kidney homogenates). A TRPM6 mRNA expression is
significantly downregulated in Prox-1DCT
KO mice (p = 0.039). mRNA
expression of B TRPM7, C EGF, D Slc41A1, E Slc41A2, F Slc41A3,
G FXYD2, H CNNM2, I ARL15, K Cldn16, L Cldn19 in total kidney
homogenates is similar in Prox-1DCT
Ctrl versus Prox-1DCT
KO mice.
Relative gene expression was analyzed with normalization against
GAPDH expression (housekeeping gene). Data are mean ± SEM,
expressed as fold difference compared to the gene expression in the
control group, n = 7. Kidneys were studied 6 weeks after start of
tamoxifen induction
Pflugers Arch - Eur J Physiol
was therefore not verifiable. Consistently, fractional cortical
DCT volume remained unchanged subsequent to a loss of
Prox-1, also indicating that Prox-1 is not directly involved in
structural epithelial remodeling processes of the DCT.
In the developing mouse kidney, Prox-1 was demonstrated
to be highly expressed in distal renal tubules, contributing to the
differentiation of the medullary part of the loop of Henle [17].
Given that a main portion of the outgrowth of the NCC-positive
rodent DCT takes place in the first 10 days perinatally [37, 38],
we investigated the effect of a Prox-1 deletion in theDCT at this
early time of life. Mice in which a Prox-1 deletion was intro-
duced during the first 10 days after birth did not reveal any
morphological renal abnormality and the cortical tubular DCT
volume remained intact, indicating that a loss of Prox-1 in this
period of nephron development does not affect DCT out-
growth. Hence, Prox-1 may be less important for the initial
formation of the DCT, but rather contributes to the regulation
of DCT function and ion transport at the full-grown stage.
The expression of NCC as the major sodium reabsorption
pathway of the DCT was significantly decreased due to a loss
of Prox-1, confirming that Prox-1 does play a modulatory role
in DCT function and ion transport regulation. As no change in
the cortical tubular DCT volume was observed in Prox-
1DCT
KO mice neither during renal development nor at adult-
hood, we assume that this NCC downregulation is not due to a
loss of DCT epithelium surface, but due to a NCC downreg-
ulation on the cellular level, which occurs as a consequence of
the genetic disruption of Prox-1. The underlying gene net-
works modified by Prox-1 and resulting in this NCC down-
regulation remain elusive. To date, the regulation of NCC
expression and phosphorylation has been understood as a
complex interplay of kinases, phosphatases and ubiquitin-
ligases [13, 34, 41, 51]. Here, we support the concept that—
in addition to the already known posttranslational regulatory
mechanisms—transcription factors previously linked to de-
velopmental processes but not epithelial transport, may par-
ticipate in the control of DCT function.
Although the abundance of NCC as the major sodium reab-
sorption pathway of the DCT is significantly reduced in Prox-
1DCT
KO mice, no functional consequences in renal sodium han-
dling, especially no salt-wasting phenotype was observed.
Consistently, NCC null mutations lead only to mild perturbation
of sodium and fluid volume homeostasis in mice [39] and most
human patients [40]. As almost every nephron segment partici-
pates in renal sodium reabsorption, compensatorymechanisms in
other tubular segments that counteract NCC downregulation in
the DCT are very likely to occur, even though no change in
ENaC protein expression was demonstrated in our study.
The DCT is also a key site for Mg2+ balance and reabsorbs
10% of filtered tubular Mg2+ in an active transcellular manner
via the luminal Mg2+ channel TRPM6 [6, 28, 46]. With this,
the DCT represents the predominant site of specifically regu-
lated Mg2+ excretion and ultimately controls the amount of
Mg2+ excreted in the urine, because no Mg2+ reabsorption
occurs in downstream nephron segments [45]. Altered DCT
structure and function either due to a genetic loss of NCC in
Gitelman syndrome or an inhibition of NCC activity by
thiazide-like diuretics may relevantly influence Mg2+ homeo-
stasis and cause renal Mg2+ wasting and hypomagnesemia in
mice [25, 31] and human patients [9, 21, 35]. Others and we
previously reported a distinct reduction of TRPM6 abundance
in a NCC null mutant mouse model, most probably linked to a
loss of a significant portion of the DCT epithelium [31, 38]. In
the current study, no change in the tubular DCT volume in
Prox-1DCT
KO mice is observed. The reduced TRPM6 expres-
sion and hypomagnesemia can hence not be explained with a
loss of TRPM6 expressing DCT epithelium. One can only
speculate whether the hypomagnesemic phenotype and
TRPM6 downregulation in the Prox-1DCT
KO mouse model is
due to a direct or indirect regulation of TRPM6 through Prox-
1 or whether this occurs secondary due to reduced NCC ex-
pression and diminished transcellular sodium transport.
Surprisingly, urinary magnesium excretion was unaltered or
even slightly reduced in Prox-1DCT
KO mice despite an overt hy-
pomagnesemia compared to the control group. This is consistent
with findings in kidney-specific TRPM6 null mice, which show
hypomagnesemia despite reduced urinary Mg2+ excretion [4]. It
is conceivable that the downregulation of TRPM6-dependent
Mg2+ transport in DCT gets compensated by an upregulation
of paracellular Mg2+ reabsorption in the TAL and PT [28].
In conclusion, we developed a new mouse model for an
inducible gene targeting in the renal DCT. We used this mouse
model to study the DCT-specific role of the transcription factor
Prox-1. While previous studies on Prox-1 and other renal tran-
scription factors focused mainly on their role during embryonic
development, the present study shows that Prox-1 has an im-
portant role in the adult DCT by controlling TRPM6-dependent
Mg2+ homeostasis. The study may set an important base for
future studies addressing the functional involvement of this
and possibly other DCT-enriched transcription factors in regu-
latory pathways governing kidney function.
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